What Can Diabetes-Associated Genetic Variation in TCF7L2 Teach Us about the Pathogenesis of Type 2 Diabetes?

J. D. Adams, Adrian Vella

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Type 2 diabetes mellitus (T2DM) is a polygenic metabolic disorder characterized by hyperglycemia occurring as a result of impaired insulin secretion and/or insulin resistance. Among the various genetic factors associated with T2DM, a common genetic variant within the transcription factor 7-like 2 locus (TCF7L2) confers the greatest genetic risk for development of the disease. However, the mechanism(s) by which TCF7L2 predisposes to diabetes remain uncertain. Here we review the current literature pertaining to the potential mechanisms by which TCF7L2 confers risk of T2DM, using genetic variation as a probe to understand the pathogenesis of the disease.

Original languageEnglish (US)
Pages (from-to)383-389
Number of pages7
JournalMetabolic Syndrome and Related Disorders
Volume16
Issue number8
DOIs
StatePublished - Oct 1 2018

Fingerprint

T Cell Transcription Factor 1
Type 2 Diabetes Mellitus
Hyperglycemia
Insulin Resistance
Insulin

Keywords

  • common genetic variation
  • insulin action
  • insulin secretion
  • type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

What Can Diabetes-Associated Genetic Variation in TCF7L2 Teach Us about the Pathogenesis of Type 2 Diabetes? / Adams, J. D.; Vella, Adrian.

In: Metabolic Syndrome and Related Disorders, Vol. 16, No. 8, 01.10.2018, p. 383-389.

Research output: Contribution to journalReview article

@article{a698518ef62d4a28bb1e9e0e25641801,
title = "What Can Diabetes-Associated Genetic Variation in TCF7L2 Teach Us about the Pathogenesis of Type 2 Diabetes?",
abstract = "Type 2 diabetes mellitus (T2DM) is a polygenic metabolic disorder characterized by hyperglycemia occurring as a result of impaired insulin secretion and/or insulin resistance. Among the various genetic factors associated with T2DM, a common genetic variant within the transcription factor 7-like 2 locus (TCF7L2) confers the greatest genetic risk for development of the disease. However, the mechanism(s) by which TCF7L2 predisposes to diabetes remain uncertain. Here we review the current literature pertaining to the potential mechanisms by which TCF7L2 confers risk of T2DM, using genetic variation as a probe to understand the pathogenesis of the disease.",
keywords = "common genetic variation, insulin action, insulin secretion, type 2 diabetes",
author = "Adams, {J. D.} and Adrian Vella",
year = "2018",
month = "10",
day = "1",
doi = "10.1089/met.2018.0024",
language = "English (US)",
volume = "16",
pages = "383--389",
journal = "Metabolic Syndrome and Related Disorders",
issn = "1540-4196",
publisher = "Mary Ann Liebert Inc.",
number = "8",

}

TY - JOUR

T1 - What Can Diabetes-Associated Genetic Variation in TCF7L2 Teach Us about the Pathogenesis of Type 2 Diabetes?

AU - Adams, J. D.

AU - Vella, Adrian

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Type 2 diabetes mellitus (T2DM) is a polygenic metabolic disorder characterized by hyperglycemia occurring as a result of impaired insulin secretion and/or insulin resistance. Among the various genetic factors associated with T2DM, a common genetic variant within the transcription factor 7-like 2 locus (TCF7L2) confers the greatest genetic risk for development of the disease. However, the mechanism(s) by which TCF7L2 predisposes to diabetes remain uncertain. Here we review the current literature pertaining to the potential mechanisms by which TCF7L2 confers risk of T2DM, using genetic variation as a probe to understand the pathogenesis of the disease.

AB - Type 2 diabetes mellitus (T2DM) is a polygenic metabolic disorder characterized by hyperglycemia occurring as a result of impaired insulin secretion and/or insulin resistance. Among the various genetic factors associated with T2DM, a common genetic variant within the transcription factor 7-like 2 locus (TCF7L2) confers the greatest genetic risk for development of the disease. However, the mechanism(s) by which TCF7L2 predisposes to diabetes remain uncertain. Here we review the current literature pertaining to the potential mechanisms by which TCF7L2 confers risk of T2DM, using genetic variation as a probe to understand the pathogenesis of the disease.

KW - common genetic variation

KW - insulin action

KW - insulin secretion

KW - type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85054403929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054403929&partnerID=8YFLogxK

U2 - 10.1089/met.2018.0024

DO - 10.1089/met.2018.0024

M3 - Review article

C2 - 29993315

AN - SCOPUS:85054403929

VL - 16

SP - 383

EP - 389

JO - Metabolic Syndrome and Related Disorders

JF - Metabolic Syndrome and Related Disorders

SN - 1540-4196

IS - 8

ER -